Basic Information
| LncRNA/CircRNA Name | circCCDC66 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | colorectal cancer |
| ICD-0-3 | C19.9 |
| Methods | qPCR |
| Sample | colorectal cancer cell lines |
| Expression Pattern | up-regulated |
| Function Description | We discovered that the expression level of circCCDC66 is elevated in colorectal cancer cells with resistance to oxaliplatin. |
| Pubmed ID | 32187976 |
| Year | 2020 |
| Title | Oxaliplatin-Induced DHX9 Phosphorylation Promotes Oncogenic Circular RNA CCDC66 Expression and Development of Chemoresistance |
External Links
| Links for circCCDC66 | GenBank HGNC NONCODE |
| Links for colorectal cancer | OMIM COSMIC |